肺动脉高压 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

文章摘要

Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Pulmonary Artery Denervation: A New, Long-Awaited Interventional Treatment for Combined Pre- and Post-Capillary Pulmonary Hypertension?
Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease
Reply: Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?
Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation
Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension
Pulmonary hypertension is associated with an increased incidence of NAFLD: A retrospective cohort study of 18,910 patients
Right ventricular expression of NT-proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension
A Notch3-Marked Subpopulation of Vascular Smooth Muscle Cells Is the Cell of Origin for Occlusive Pulmonary Vascular Lesions.
The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension

Original Research

2021 Jul 2;zuab033.

JOURNAL：Eur Heart J Acute Cardiovasc Care.

'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial

AS Gamal, H Hara, PW Serruys et al.

8493

Keywords: DAPT; GLOBAL LEADERS; PCI; Ticagrelor; STEMI

Full Text PDF